Epigenetics Drugs and Diagnostic Technologies Market To Witness Huge Potential In The Future
Epigenetics Drugs and Diagnostic Technologies Industry The global epigenetics drugs & diagnostic technologies market size is expected to reach USD 39.2 billion by 2030, registering a CAGR of 14.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising incidence of cancer with epigenetic modification base is projected to drive the market growth. Diagnostic firms are focused on developing new treatments such as antibodies specific for detection of epigenetic modifications and advanced kits for effective detection of biomarkers. It is likely to encourage pharmaceutical firms to partner for development of new advanced treatments which will further accelerate the market growth. Presence of a large number of products under clinical trials and their projected commercialization is likely to boost the market. For instance, Eli Lilly’s Ramucirumab have been approved by the U.S. Food and Drug Administration (FDA) to be used in combination with...